InMed Pharmaceuticals Inc. (INM) NASDAQ
0.77
-0.029(-3.63%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.77
-0.029(-3.63%)
Currency In USD
| Market Cap | 3.17M |
| Enterprise Value | -10.91M |
| P/E Ratio | -0 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.26 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | -1.4 |
| Enterprise/EBITDA | 0.85 |
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.72 |
| Operating Margin | -1.75 |
| Return On Assets | -0.59 |
| Return On Equity | -0.63 |
| Revenue | 4.94M |
| Revenue/Share | 1,336.43 |
| Gross Profit | 1.71M |
| EBITDA | -7.26M |
| Net Income | -8.16M |
| Diluted EPS | -11.44 |
| Total Cash | 9.6M |
| Total Cash/Share | 2,429.08 |
| Total Debt | 730,137 |
| Total Debt/Equity | 0.06 |
| Current Ratio | 5.94 |
| Book Value Per Share | 3,328.21 |
| 52-Week Change | -72.66 |
| 52-Week High | 7.98 |
| 52-Week Low | 0.73 |
| Moving Average 50 Days | 1 |
| Moving Average 200 Days | 1.89 |
| Average Volume | 95,905 |
| Shares Outstanding | 1.81M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | November 14, 2024 |